Next-Generation AI Tools for Molecular Discovery: Flare™ V13 Unveiled
Online
November 11, 2026
Join us on 11 November for an in-depth look at the latest innovations in Flare™ V13 featuring AI-driven molecular design, advanced 3D similarity technology, and enhanced FEP calculations – enabling researchers to make smarter design decisions earlier in the drug discovery process.
Webinar: Computational strategies for next-generation protein degraders
Online
November 4, 2026
Join us on 4 November as we explore computational strategies for accelerating degrader design using the STAT5 and CRBN-targeting ligand, AK2292 as a case study. You will gain insight into how large-scale chemical databases can be leveraged to access innovative linker chemotypes, and how the combination of computational degrader design and commercially accessible chemistry can streamline the discovery of next-generation protein degraders.
Cresset launches Flare AI Client, helping computational chemists complete hours of work in minutes
Scientists can now connect company-approved AI providers such as Claude Code and GitHub Copilot directly to Flare, helping teams set up, execute, and analyze complex computational chemistry workflows in minutes not hours.
Flare™ V13 released: Discover better molecules faster with AI-powered new molecule generation and R-group exploration in 3D
Flare V13 is here, bringing a powerful new set of AI tools to the platform plus enhancements to Relative FEP.
Cresset Discovery accelerates optimization of METTL3 inhibitor
Cresset Discovery has delivered a highly efficient digital workflow combining their molecular modeling expertise with Cresset technology to accelerate discovery, design and optimization of a METTL3 inhibitor.